These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 6145454

  • 1. Do neuroleptics cause depression?
    Roy A.
    Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
    [Abstract] [Full Text] [Related]

  • 2. Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
    Wistedt B, Palmstierna T.
    J Clin Psychiatry; 1983 Oct; 44(10):369-71. PubMed ID: 6643398
    [Abstract] [Full Text] [Related]

  • 3. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR, Liddle PF, Curson DA, Patel M.
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP.
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacogenic depression among outpatient schizophrenic patients: a failure to substantiate.
    Hogarty GE, Munetz MR.
    J Clin Psychopharmacol; 1984 Feb; 4(1):17-24. PubMed ID: 6141187
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S, Dollfus S, Lesieur P, Petit M.
    Encephale; 1994 Feb; 20(5):487-93. PubMed ID: 7828511
    [Abstract] [Full Text] [Related]

  • 7. "Postpsychotic depression" and residual schizophrenia in a mental health hospital.
    Mauri MC, Laini V, Barone R, Clemente A, Volonteri LS, Cerveri G, Steinhilber C, Fornier M.
    Encephale; 2000 Feb; 26(6):21-6. PubMed ID: 11217534
    [Abstract] [Full Text] [Related]

  • 8. Frequency and differential diagnosis of depressive syndromes in schizophrenia.
    Martin RL, Cloninger CR, Guze SB, Clayton PJ.
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):9-13. PubMed ID: 2865255
    [Abstract] [Full Text] [Related]

  • 9. Depressive states occurring during the neuroleptic treatment of schizophrenia.
    Möller HJ, von Zerssen D.
    Schizophr Bull; 1982 Nov; 8(1):109-17. PubMed ID: 6122264
    [Abstract] [Full Text] [Related]

  • 10. Schizophrenic patients before and after HIV infection: a case-control study.
    Mauri MC, Fabiano L, Bravin S, Ricci C, Invernizzi G.
    Encephale; 1997 Nov; 23(6):437-41. PubMed ID: 9488926
    [Abstract] [Full Text] [Related]

  • 11. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S, Adler L, Angrist B, Peselow E, Rotrosen J.
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [Abstract] [Full Text] [Related]

  • 12. Depressive symptoms and schizophrenia a psychopharmacological approach.
    Mauri MC, Bravin S, Fabiano L, Vanni S, Boscati L, Invernizzi G.
    Encephale; 1995 Jan; 21(5):555-8. PubMed ID: 8529564
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis of secondary depression in schizophrenia.
    Becker RE, Colliver JA, Verhulst SJ.
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):4-8. PubMed ID: 4055721
    [Abstract] [Full Text] [Related]

  • 14. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS, Zimmerman RL.
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
    Lee KU, Jeon YW, Lee HK, Jun TY.
    Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
    [Abstract] [Full Text] [Related]

  • 16. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC.
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [Abstract] [Full Text] [Related]

  • 17. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G, Noisette C, Legrand A, Delahousse J.
    Encephale; 1997 Jun; 23(1):10-8. PubMed ID: 9172962
    [Abstract] [Full Text] [Related]

  • 18. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT, Rada RT.
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [Abstract] [Full Text] [Related]

  • 19. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S, Lieberman J, Pollack S, Kane JM, Safferman A, Munne R, Umbricht D, Woerner M, Masiar S, Kronig M.
    Biol Psychiatry; 1996 Feb 15; 39(4):249-54. PubMed ID: 8645771
    [Abstract] [Full Text] [Related]

  • 20. Novel neuroleptics in schizophrenia: theory and clinical relevance.
    Remington GJ.
    Can J Psychiatry; 1994 Nov 15; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.